Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period-Reference-Cited by-同舟云学术

Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period

Published:2016-01-22 Issue:4 Volume:7 Page:555-564
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Araki Eiichi¹,Onishi Yukiko²,Asano Michiko³,Kim Hyosung³,Ekholm Ella⁴,Johnsson Eva⁴,Yajima Toshitaka³

Affiliation:

1. Department of Metabolic Medicine Faculty of Life Sciences Kumamoto University Kumamoto Japan

2. The Institute for Adult Diseases Asahi Life Foundation Tokyo Japan

3. AstraZeneca K.K. Osaka Japan

4. AstraZeneca R&D Mölndal Sweden

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.12453

Reference28 articles.

1. Pathophysiology and Pharmacological Treatment of Insulin Resistance

2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

4. Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20)

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis;The Journal of Clinical Pharmacology;2024-08

2. Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;Osteoporosis International;2023-09-11

3. Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2023-08-28

4. Analytical Method Development, Validation and Forced Degradation Study of Dapagliflozin by RP-HPLC;Drug Metabolism and Bioanalysis Letters;2023-07

5. Aspects of the safety of hypoglycemic drugs according to the results of clinical trials;Patient-Oriented Medicine and Pharmacy;2023-06-07